The co-inertia approach in identification of specific microRNA in early and advanced atherosclerosis plaque

Medical Hypotheses

Volumn 83, Issue 1, 2014, Pages 11-15

  Jovanović, Ivan ^a   Živković, Maja ^a   Jovanović, Jasmina ^b   Djurić, Tamara ^a   Stanković, Aleksandra ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 100; MICRORNA 124; MICRORNA 127; MICRORNA 134; MICRORNA 145; MICRORNA 146A; MICRORNA 146B; MICRORNA 155; MICRORNA 182; MICRORNA 184; MICRORNA 190; MICRORNA 198; MICRORNA 21; MICRORNA 213; MICRORNA 217; MICRORNA 221; MICRORNA 222; MICRORNA 24; MICRORNA 302A; MICRORNA 302B; MICRORNA 31; MICRORNA 320; MICRORNA 323; MICRORNA 324; MICRORNA 34C; MICRORNA 368; MICRORNA 371; MICRORNA 372; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALGORITHM; ARTICLE; ATHEROSCLEROTIC PLAQUE; CO INERTIA ANALYSIS; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HYPOTHESIS; MATHEMATICAL ANALYSIS; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHENOTYPE; POLYMERASE CHAIN REACTION SYSTEM; GENE EXPRESSION PROFILING; GENETICS; METABOLISM;

GENE EXPRESSION PROFILING; HUMANS; MICRORNAS; PLAQUE, ATHEROSCLEROTIC;

EID: 84901060695     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2014.04.019     Document Type: Article

References (37)

1. Adiguzel E., Ahmad P.J., Franco C., Bendeck M.P. Collagens in the progression and complications of atherosclerosis. Vasc Med (London, England) 2009, 14:73-89.
2. Chen K., Rajewsky N. The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet 2007, 8:93-103.
3. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
4. Krek A., Grun D., Poy M.N., et al. Combinatorial microRNA target predictions. Nat Genet 2005, 37:495-500.
5. Lewis B.P., Shih I.H., Jones-Rhoades M.W., Bartel D.P., Burge C.B. Prediction of mammalian microRNA targets. Cell 2003, 115:787-798.
6. Dray S., Chessel D., Thioulouse J. Co-inertia analysis and the linking of ecological data tables. Ecology 2003, 84:3078-3089.
7. DoléDec S., Chessel D. Co-inertia analysis: an alternative method for studying species-environment relationships. Freshwater Biol 1994, 31:277-294.
8. Madden S., Carpenter S., Jeffery I., et al. Detecting microRNA activity from gene expression data. BMC Bioinformatics 2010, 11:257.
9. Culhane A.C., Perriere G., Considine E.C., Cotter T.G., Higgins D.G. Between-group analysis of microarray data. Bioinformatics 2002, 18:1600-1608.
10. Mulrane L., Madden S.F., Brennan D.J., et al. MiR-187 is an independent prognostic factor in breast cancer and confers increased invasive potential in vitro. Clin Cancer Res 2012, 18:6702-6713.
11. Raitoharju E., Lyytikäinen L.-P., Levula M., et al. MiR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. Atherosclerosis 2011, 219:211-217.
12. Levula M., Oksala N., Airla N., et al. Genes involved in systemic and arterial bed dependent atherosclerosis - Tampere Vascular study. PLoS One 2012, 7:e33787.
13. Virmani R., Kolodgie F.D., Burke A.P., Farb A., Schwartz S.M. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000, 20:1262-1275.
14. Irizarry R.A., Hobbs B., Collin F., et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics (Oxford, England) 2003, 4:249-264.
15. Gautier L., Cope L., Bolstad B.M., Irizarry R.A. Affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 2004, 20:307-315.
16. Jeffery I.B., Madden S.F., McGettigan P.A., Perrière G., Culhane A.C., Higgins D.G. Integrating transcription factor binding site information with gene expression datasets. Bioinformatics 2007, 23:298-305.
17. Culhane A.C., Thioulouse J., Perriere G., Higgins D.G. MADE4: an R package for multivariate analysis of gene expression data. Bioinformatics 2005, 21:2789-2790.
18. Nicoli S., Knyphausen C.-P., Zhu Lihua J., Lakshmanan A., Lawson Nathan D. miR-221 Is required for endothelial tip cell behaviors during vascular development. Dev Cell 2012, 22:418-429.
19. Dentelli P., Rosso A., Orso F., Olgasi C., Taverna D., Brizzi M.F. MicroRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression. Arterioscler Thromb Vasc Biol 2010, 30:1562-1568.
20. Ji R., Cheng Y., Yue J., et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of microrna in vascular neointimal lesion formation. Circ Res 2007, 100:1579-1588.
21. Cipollone F., Felicioni L., Sarzani R., et al. A unique microRNA signature associated with plaque instability in humans. Stroke 2011, 42:2556-2563.
22. Sun S.G., Zheng B., Han M., et al. MiR-146a and Kruppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation. EMBO Rep 2011, 12:56-62.
23. Takahashi Y., Satoh M., Minami Y., Tabuchi T., Itoh T., Nakamura M. Expression of miR-146a/b is associated with the Toll-like receptor 4 signal in coronary artery disease: effect of renin-angiotensin system blockade and statins on miRNA-146a/b and Toll-like receptor 4 levels. Clin Sci (London, England) 1979, 119(2010):395-405.
24. Grundmann S., Hans F.P., Kinniry S., et al. MicroRNA-100 regulates neovascularization by suppression of mammalian target of rapamycin in endothelial and vascular smooth muscle cells. Circulation 2011, 123:999-1009.
25. Cheng Y., Liu X., Yang J., et al. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator controls vascular neointimal lesion formation. Circ Res 2009, 105:158-166.
26. Cordes K.R., Sheehy N.T., White M.P., et al. MiR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009, 460:705-710.
27. Zhu N., Zhang D., Chen S., et al. Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration. Atherosclerosis 2011, 215:286-293.
28. Huang R.S., Hu G.Q., Lin B., Lin Z.Y., Sun C.C. MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages. J Investig Med 2010, 58:961-967.
29. Wei Y., Nazari-Jahantigh M., Neth P., Weber C., Schober A. MicroRNA-126, -145, and -155: a therapeutic triad in atherosclerosis?. Arterioscler Thromb Vasc Biol. 2013, 33:449-454.
30. Fichtlscherer S., De Rosa S., Fox H., et al. Circulating microRNAs in patients with coronary artery disease. Circ Res 2010, 107:677-684.
31. Sun F., Wang J., Pan Q., et al. Characterization of function and regulation of miR-24-1 and miR-31. Biochem Biophys Res Commun 2009, 380:660-665.
32. Mishra P.J., Song B., Mishra P.J., Wang Y., et al. MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism. PLoS One 2009, 4:e8445.
33. Zhou Q., Gallagher R., Ufret-Vincenty R., Li X., Olson E.N., Wang S. Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23~27~24 clusters. Proc Natl Acad Sci U S A 2011, 108:8287-8292.
34. Esau C., Davis S., Murray S.F., et al. MiR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 2006, 3:87-98.
35. Raitoharju E., Oksala N., Lehtimaki T. MicroRNAs in the atheroclerotic plaque. Clin Chem 2013, 59:1708-1721.
36. Gennarino V.A., D'Angelo G., Dharmalingam G., et al. Identification of microRNA-regulated gene networks by expression analysis of target genes. Genome Res 2012, 22:1163-1172.
37. Jin Y., Tymen S.D., Chen D., et al. MicroRNA-99 family targets AKT/mTOR signaling pathway in dermal wound healing. PLoS One 2013, 8:e64434.